{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:39:07Z","timestamp":1762004347698},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s11985","type":"journal-article","created":{"date-parts":[[2011,11,13]],"date-time":"2011-11-13T15:21:15Z","timestamp":1321197675000},"page":"155","source":"Crossref","is-referenced-by-count":28,"title":["Update on role of agalsidase alfa in management of Fabry disease"],"prefix":"10.2147","author":[{"given":"Uma","family":"Ramaswami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,3]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=9241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:02:51Z","timestamp":1477850571000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/update-on-role-of-agalsidase-alfa-in-management-of-fabry-disease-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s11985","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}